Digital Migraine Treatment Device Market 2022: Worldwide Industry Analysis of Development, Revenue and Gross Margin by 2032

Healthcare

Market Overview

The occurrence of spasmodic headache is termed as a medical condition called as migraine. The onset of migraine is generally experienced by approximately 15% of the world population. The symptoms include mild to severe headache and issues pertaining sensitivity to light and sound. The expensive dependence on pharmaceutical drugs and therapies which are invasive, impeding with the implants, causing overuse and associated side effects.

While the current treatments include triptans and ergots patients are shifting towards more specific digital migraine treatment devices. Neuromodulation is primarily the technology driving the patients towards the growth of the digital migraine treatment devices. The USFDA gave de novo clearance to Thranica’s Nevirio Migra, a smartphone connected device giving other manufacturers an aspiration to enter the untapped markets.

Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=3995

Digital Migraine Treatment Devices Market: Key Players

There are few key players operating in the digital migraine treatment devices market like

  • Theranica Bio-Electronics LTD
  • electroCore, Inc.
  • Cirrus Healthcare Products
  • Cefaly Technology
  • eNeura Inc.
  • Prolivio
  • Neuros Medical

Digital Migraine Treatment Device Market: Regional Outlook

Geographically, the global digital migraine treatment devices market is segmented into seven regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America is expected to be a dominant market in the global digital migraine treatment devices market because of the presence of well-established healthcare infrastructure and availability of advanced healthcare facilities.

The Asia Pacific is expected to hold a significant growth rate of digital migraine treatment devices market. The digital migraine treatment devices market in the Asia Pacific is expected to grow at a significant CAGR due to the presence of a large population. Europe is also expected to hold a large revenue share in the digital migraine treatment devices market owing to the increasing R&D funding and increasing healthcare awareness.

Digital Migraine Treatment Device Market: Segmentation

Tentatively, the global Digital Migraine Treatment Devices market can be segmented on the basis of the technology, end user, and geography.

Based on the technology, the global digital migraine treatment devices market is segmented as:

  • Supraorbital stimulation digital migraine treatment devices
  • Vagus nerve stimulation digital migraine treatment devices (VNS)
  • Single-pulse transcranial magnetic stimulation digital migraine treatment devices (sTMS)
  • Occipital nerve stimulation digital migraine treatment devices (ONS)

Based on end user, the global digital migraine treatment devices market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Pharmacies

Leave a Reply

Related Posts